*Nancy Hassan Abd Elhamid Bakri, Ageeb Mohammed Hassan


Colorectal cancer is the fourth most common cancer in the world with approximately 875.000 new cases per year in the worldwide accounting for 8.5% of all new cancer. This study was aimed to detect CDX2 expression among Sudanese patients with colorectal cancer. This study was conducted at Soba University Hospital during the period (June 2018 to November 2019). Forty samples of paraffin wax blocks from patient diagnosed as colorectal carcinoma collected in tissue micro-array slide. The study was used a standard avidin- biotin- peroxidase complex method with monoclonal antibodies against CDX2 for its detection. SPSS version 21 was used to analyze the data. The age range was from 31-80 years old with mean of 55 years old and was devided into two groups less than 40 years old and more than 40 years old. Association between age group and CDX2 expression, showed that (33.3%) had presence of CDX2 and 4(14.3%) had absent of CDX2 among less 40 years old while (66.7%) had present of CDX2 and (85.7%) had absent of CDX2 among more than 40 years old. There was no significant difference in proportion between the two groups. Association between gender of patient and CDX2expression, the showed that male (12.5%) had present of CDX2 and (45.5%) had absent of CDX2, and show female (17.5%) had present of CDX2 and (25.0%) absent of CDX2.Association between stage of the disease and CDX2 expression, (30.8%) of C colorectal cancer patients in stage C had present of CDX2 and (69.2%) of them had absent of CDX2, while (28.6%) of colorectal cancer patients in stage D had present of CDX2 and (71.4%) of them had absent of CDX2. Conclusion: in this study showed CDX2 expresses in patients less than 40years with colorectal adenocarcinoma less than patients above 40years, in female more than male and expresses in stage C more than stage D.

Keywords: Colorectal cancer, CDX2.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    AUGUST 2022 Issue has been successfully launched on 1 August 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction